- Clinical Trials
- April 2024
- 550 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Clinical Trials
- April 2024
- 220 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2883EUR$3,000USD£2,473GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Drug Pipelines
- March 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,236GBP
- Clinical Trials
- January 2024
- 100 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,236GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1442EUR$1,500USD£1,236GBP
- Report
- November 2023
- 30 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Report
- June 2019
- 80 Pages
Global
From €1249EUR$1,299USD£1,071GBP
From €300EUR$334USD£266GBP
- Report
- May 2023
- 450 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- May 2023
- 220 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- April 2020
- 80 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Drug Pipelines
- September 2019
- 114 Pages
Global
€9612EUR$10,000USD£8,242GBP
- Drug Pipelines
- February 2020
- 66 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Drug Pipelines
- March 2019
- 97 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Book
- April 2010
- 351 Pages
The Antigen Presenting Cell (APC) market is a subset of the Immune Disorders Drugs market. APCs are specialized cells that play a key role in the immune system by recognizing and presenting antigens to other cells of the immune system. APCs are used in the development of drugs for a variety of immune disorders, including autoimmune diseases, allergies, and cancer. APCs are also used in the development of vaccines, as they are able to recognize and present antigens to the immune system, triggering an immune response.
The APC market is expected to grow in the coming years, driven by the increasing prevalence of immune disorders and the development of new treatments. Additionally, the increasing demand for personalized medicine is expected to drive the growth of the APC market.
Some companies in the APC market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, and Miltenyi Biotec. Show Less Read more